During the last century, there has been an increasing prevalence of hyperuricaemia noted in many populations. While uric acid is usually discussed in the context of gout …
Gout and hyperuricemia are present in 25% and 60% of patients with chronic kidney disease (CKD), respectively. Despite the common association, the role of uric acid in the …
JT Kielstein, R Pontremoli, M Burnier - Current Hypertension Reports, 2020 - Springer
Abstract Purpose of Review In chronic kidney disease (CKD), plasma uric acid levels are increased because of the decrease in glomerular filtration rate. However, in addition to CKD …
This review aims to critically present the available clinical evidence supporting the treatment of chronic hyperuricemia with xanthine oxidase inhibitors. For this reason, the studies …
A Niculae, ME Gherghina, I Peride, M Tiglis… - International Journal of …, 2023 - mdpi.com
Acute kidney injury (AKI) is one of the main conditions responsible for chronic kidney disease (CKD), including end-stage renal disease (ESRD) as a long-term complication …
The relationship between hyperuricemia, gout, and renal disease has been investigated for several years. From the beginning, kidney disease has been considered a complication of …
C Jenkins, JH Hwang, JB Kopp, CA Winkler… - Frontiers in …, 2022 - frontiersin.org
We reviewed all currently available ULT, as well as any medications in development using following databases: United States Food and Drug Administration (FDA), European …
JS Sohn, JS Choi - International Journal of Biological Macromolecules, 2023 - Elsevier
Drug solubilization studies are continuously being conducted. Febuxostat (FBX) has a low solubility in water. This study aims to develop a stable FBX-solid dispersion (SD) formulation …
P Balakumar, A Alqahtani, NA Khan… - Pharmacological …, 2020 - Elsevier
Though the pathogenesis of hyperuricemia-induced renal complications is not precisely known, hyperuricemia has been recognized as an independent risk factor for renal disease …